Stem Cell Research
Human neural stem cell lines are stable when cultured for long periods
Published in Blood Weekly, May 20th, 2004
According to published research from Spain, "human neural stem cells (hNSCs) are excellent candidates for in vitro and in vivo molecular, cellular, and developmental research, and also for ex-vivo gene transfer and cell therapy in the nervous system. However, hNSCs are mortal somatic cells, and thus invariably enter an irreversible growth arrest after a finite number of cell divisions in culture. It has been proposed that this is due to telomere shortening.
"Here, we show that long-term cultured (up to 4 years) v-myc perpetuated hNSC lines do preserve short but stable and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-05-20)
More Articles from Blood Weekly
- Adverse Drug Effects
Long-term studies show transduced stem cells do not cause leukemia - Cancer Risk Factor
Celiac disease not a risk factor for lymphoma - Drug Delivery
Heparin-coated nanoparticles show promise as oxygen carriers - HIV/AIDS
Company presents data on its therapeutic vaccine approach for HIV infection - Liver Damage
Preclinical data presented on histamine's ability to prevent liver damage - Acute Myeloid Leukemia
Adult patients with t(8;21) AML had similar outcomes as non-t(8;21) patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
